Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.67 |
| ▸ | P2RX1 | P51575 | 8/20 | 0.59 |
| ▸ | TMPRSS4 | Q9NRS4 | 5/20 | 0.58 |
| ▸ | P2RX4 | Q99571 | 3/20 | 0.58 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.58 |
| ▸ | KCNMA1 | Q12791 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.51 |
| ▸ | XBP1 | P17861 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.51 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL30207997 | 0.98 | CA1 (0.64) | CA1CA2P2RX1TMPRSS4P2RX4 | |
| Hydrochloric Acid SCHEMBL11784623 | 0.98 | CA1 (0.64) | CA1CA2P2RX1TMPRSS4P2RX4 | |
| SCHEMBL9739457 | 0.86 | CA1 (0.51) | CA1CA2P2RX1TMPRSS4P2RX4 | |
| SCHEMBL17233413 | 0.84 | ALOX5 (0.57) | CA1CA2P2RX1TMPRSS4P2RX4 | |
| SCHEMBL3922668 | 0.83 | ALDH1A1 (0.47) | CA1CA2P2RX1TMPRSS4KCNMA1 | |
| SCHEMBL498707 | 0.83 | MAOB (0.58) | CA1CA2P2RX1TMPRSS4P2RX4 | |
| SCHEMBL29495428 | 0.83 | MAOB (0.58) | CA1CA2P2RX1TMPRSS4P2RX4 | |
| SCHEMBL20117002 | 0.82 | ALDH1A1 (0.50) | CA1CA2P2RX1MEN1MAPT | |
| SCHEMBL6966672 | 0.82 | CA1 (0.72) | CA1CA2P2RX1TMPRSS4P2RX4 | |
| 5-Chlorosalicylic Acid SCHEMBL28240558 | 0.81 | CA1 (0.92) | CA1CA2P2RX1TMPRSS4P2RX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 474 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116813569-B | Preparation method of anticancer drug intermediate and preparation method of anticancer drug | 衡阳市中心医院 | 2024-07-02 | — | — | CN | claimed |
| CN-116813569-A | Preparation method of anticancer drug intermediate and preparation method of anticancer drug | 衡阳市中心医院 | 2023-09-29 | — | — | CN | claimed |
| WO-2022256358-A1 | PROCESS FOR PREPARING MEDICAMENTS | GENENTECH, INC. (US) | 2022-12-08 | — | — | WO | claimed |
| CN-115259150-A | Production process of biomass-based hard carbon material based on high-temperature sintering modification | 江苏智纬电子科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-114751870-A | 2- (isoxazole-5-yl) phenyl-3, 4-dihydroxy benzoate and derivative thereof, and synthesis method and application thereof | 贵州医科大学 | 2022-07-15 | — | — | CN | claimed |
| CN-111996222-A | Method for preparing drug intermediate (R) -2- (aminoethyl) -4-chlorophenol by adopting enzyme mutation technology | 赣江新区生鸿企业管理中心(有限合伙) | 2020-11-27 | — | — | CN | claimed |
| CN-107698452-B | Synthetic method of 3-amino-2-hydroxyacetophenone | 黑龙江鑫创生物科技开发有限公司 | 2020-06-02 | — | — | CN | claimed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| US-20060269494-A1 | New Ubiquitin-Proteasome Regulating Compounds and Their Application in Cosmetic and Pharmaceutical Formulations | GUPTA SHYAM K | 2006-11-30 | — | — | US | claimed |
| US-20060110415-A1 | Topical Delivery System for Cosmetic and Pharmaceutical Agents | BIODERM RESEARCH (US) | 2006-05-25 | — | — | US | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| US-20050271608-A1 | Skin whitening compositions based on hydroxyaryl alkyl ketones and their isosteric derivatives | GUPTA SHYAM K | 2005-12-08 | — | — | US | claimed |
| JP-9040619-A | — | — | None | — | — | JP | disclosed |
| EP-3558298-B1 | ANTIDIABETIC SPIROCHROMAN COMPOUNDS | MERCK SHARP & DOHME LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-3974434-B1 | MACROLIDE DERIVATIVES, PREPARATION METHOD AND APPLICATION THEREOF | ZHEJIANG HISUN PHARM CO LTD (CN) | 2025-11-19 | — | — | EP | disclosed |
| US-12410191-B2 | Macrolide derivatives, preparation method and application thereof | ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) | 2025-09-09 | — | — | US | disclosed |
| US-4002423-A | Benzofuran derivatives process for their preparation and their use as optical brighteners | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-01-11 | — | — | US | disclosed |
| US-3994902-A | Certain 1,2-diphenyl-1,2,3,4-tetrahydroquinoline compounds | STERLING DRUG INC. (US) | 1976-11-30 | — | — | US | disclosed |
| US-3956369-A | N-β-(2-acetyl-4-chlorophenoxy)-ethyl-N,N-dimethyl-N-benzyl-ammonium-p-chlorobenzene sulphonate, method for preparing same and medicinal preparation based thereon | OZERETSKOVSKAYA NATALIA NIKOLA | 1976-05-11 | — | — | US | disclosed |
| US-3956369-A | N-β-(2-acetyl-4-chlorophenoxy)-ethyl-N,N-dimethyl-N-benzyl-ammonium-p-chlorobenzene sulphonate, method for preparing same and medicinal preparation based thereon | OZERETSKOVSKAYA NATALIA NIKOLA | 1976-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410191-B2 | Macrolide derivatives, preparation method and application thereof | ROS1, IRAK1, IRAK2 | CA1 4881/4885CA2 4700/4885P2RX1 4203/4885 |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | PSMB1, PLOD3, CUTA | CA1 4867/4885CA2 4627/4885P2RX1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.